Terms: = Lung cancer AND NUMA1, Q14980, 4926, ENSG00000137497, NUMA
11 results:
1. cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by
D'Ambrosio C; Erriquez J; Capellero S; Cignetto S; Alvaro M; Ciamporcero E; Di Renzo MF; Perera T; Valabrega G; Olivero M
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628590
[TBL] [Abstract] [Full Text] [Related]
2. A genome-wide enrichment screen identifies numa1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.
Gisler S; Maia ARR; Chandrasekaran G; Kopparam J; van Lohuizen M
PLoS One; 2020; 15(4):e0227592. PubMed ID: 32343689
[TBL] [Abstract] [Full Text] [Related]
3. Drug Targeting the Actin Cytoskeleton Potentiates the Cytotoxicity of Low Dose Vincristine by Abrogating Actin-Mediated Repair of Spindle Defects.
Wang Y; Stear JH; Swain A; Xu X; Bryce NS; Carnell M; Alieva IB; Dugina VB; Cripe TP; Stehn J; Hardeman EC; Gunning PW
Mol Cancer Res; 2020 Jul; 18(7):1074-1087. PubMed ID: 32269073
[TBL] [Abstract] [Full Text] [Related]
4. Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma.
Wagner F; Holzapfel BM; McGovern JA; Shafiee A; Baldwin JG; Martine LC; Lahr CA; Wunner FM; Friis T; Bas O; Boxberg M; Prodinger PM; Shokoohmand A; Moi D; Mazzieri R; Loessner D; Hutmacher DW
Biomaterials; 2018 Jul; 171():230-246. PubMed ID: 29705656
[TBL] [Abstract] [Full Text] [Related]
5. Multi-GPU configuration of 4D intensity modulated radiation therapy inverse planning using global optimization.
Hagan A; Sawant A; Folkerts M; Modiri A
Phys Med Biol; 2018 Jan; 63(2):025028. PubMed ID: 29176059
[TBL] [Abstract] [Full Text] [Related]
6. Tankyrase as a Novel Molecular Target in cancer and Fibrotic Diseases.
Lakshmi TV; Bale S; Khurana A; Godugu C
Curr Drug Targets; 2017; 18(10):1214-1224. PubMed ID: 27425647
[TBL] [Abstract] [Full Text] [Related]
7. Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis.
Pillai S; Nguyen J; Johnson J; Haura E; Coppola D; Chellappan S
Nat Commun; 2015 Dec; 6():10072. PubMed ID: 26656453
[TBL] [Abstract] [Full Text] [Related]
8. numa is required for the selective induction of p53 target genes.
Ohata H; Miyazaki M; Otomo R; Matsushima-Hibiya Y; Otsubo C; Nagase T; Arakawa H; Yokota J; Nakagama H; Taya Y; Enari M
Mol Cell Biol; 2013 Jun; 33(12):2447-57. PubMed ID: 23589328
[TBL] [Abstract] [Full Text] [Related]
9. Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs.
Umekawa K; Kimura T; Kudoh S; Suzumura T; Oka T; Nagata M; Mitsuoka S; Matsuura K; Nakai T; Yoshimura N; Kira Y; Hirata K
BMC Res Notes; 2013 Apr; 6():139. PubMed ID: 23566546
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear mitotic apparatus protein (numa) in benign and malignant diseases.
Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt UM; Schmeller N; Schalhorn A
Anticancer Res; 1999; 19(4A):2415-20. PubMed ID: 10470168
[TBL] [Abstract] [Full Text] [Related]
11. The role of numa in the interphase nucleus.
Merdes A; Cleveland DW
J Cell Sci; 1998 Jan; 111 ( Pt 1)():71-9. PubMed ID: 9394013
[TBL] [Abstract] [Full Text] [Related]
